Can a smartphone app ease anxiety in older adults? new study aims to find out
NCT ID NCT05754151
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a mobile app called MAYA that teaches cognitive behavioral therapy (CBT) skills to help older adults manage anxiety and depression. About 60 participants aged 40 and older with an anxiety or depressive disorder will use the app for at least 20 minutes, twice a week, for six weeks. Researchers will measure how acceptable and feasible the app is, and whether symptoms improve.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MAYA mobile app (cognitive behavioral therapy)
- What this could lead to
- If successful, this could provide a convenient, app-based tool to help older adults manage anxiety and depression symptoms at home.
- What could go wrong
- This is a small early feasibility study with only 60 participants, so results may not apply to everyone. The app requires an iPhone and regular use, which may not suit all users.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS AND SYMPTOMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Weill Cornell Medicine
RECRUITINGNew York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can a coordinated care team ease the aftermath of intensive care?
- Could a new drug offer hope for Treatment-Resistant depression?